Previous 10 | Next 10 |
home / stock / invvy / invvy news
EVO Payments, Inc. (EVOP) Q1 2019 Earnings Conference Call May 2, 2019 08:00 ET Company Participants Shaun Thaxter - CEO Mark Crossley - CFO Christian Heidbreder - Chief Scientific Officer Conference Call Participants Harry Sephton - Jefferies Max Herrmann - Stifel Nick...
The following slide deck was published by Indivior PLC in conjunction with their 2019 Q1 earnings Read more ...
SLOUGH, England and RICHMOND, Va. , May 2, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its first quarter 2019 press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of...
Aquestive Therapeutics ( AQST ) has been on my radar since its IPO back in July of 2018. Unfortunately, the company has had a few regulatory setbacks with some partnered and secondary product candidates that have cut the share price. These setbacks have prevented me from buying into the stoc...
SAN DIEGO, CA / ACCESSWIRE / April 29, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Indivior PLC (OTC: INVVY) shares. Investors, who purchased shares of Indivior PLC (OTC: INVVY), have certain options and should contact the Shareholde...
NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Indivior PLC (“Indivior” or the “Company”) (Other OTC:INVVY) of the June 24, 2019 deadline to seek the role of lead plaintiff in a ...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Indivior PLC (“Indivior” or the “Company”) (OTC: INVVY ) investors concerning the Company and its officers’ possible violations of federal securities laws. ...
SAN FRANCISCO , April 11, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Indivior PLC (OTC: INVVY) to the firm's investigation of possible Federal securities law violations. If you purchased or otherwise acquired Indivior securities before March 10, ...
Indivior PLC ( OTCPK:INVVY ) has plummeted 78% on the London Stock Exchange (listed under the ticker "INDV") in reaction to an indictment by a federal grand jury in Virginia of fraud related to the marketing of its opioid addiction treatments, specifically, its Suboxone Film. ...
SLOUGH, United Kingdom and RICHMOND, Va. , April 9, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) issued the following statement today in response to an indictment returned by a federal grand jury in the Western District of Virginia : "We are extremely disappointed in thi...
News, Short Squeeze, Breakout and More Instantly...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance PR Newswire RICHMOND, Va. , May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation o...
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...